🔎 Trials Near Me

Hjem › Plateepitelkarcinom › Massachusetts

Kliniske studier for Plateepitelkarcinom i Massachusetts

8 studier for Plateepitelkarcinom søker deltakere på steder i Massachusetts.

Byer i Massachusetts

Offisiell studietekst (engelsk)

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • Boston Medical Center, Boston
RekruttererFase 3
Alder 60 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04892173

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Tufts Medical Center, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06047379

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06561685

Toripalimab With Chemotherapy for Sinus Cancer

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT06940180

PDT For Induction Therapy For Head And Neck Cancer

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT07214987

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06064877

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. okt. 2025 · NCT04370587

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Dana Farber/Partners Cancer Care Inc, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. aug. 2025 · NCT04429542

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.